CFO
MDLN

Callan Family Office’s Medline Inc MDLN Stock Holding History

Callan Family Office’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$485K Buy
12,297
+1,899
+18% +$76.5K 0.01% 829
2026
Q1 		$463K Buy
+10,398
New +$459K 0.01% 791

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
ECU
Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Callan Family Office's MDLN Position: Q2 2026 in Review

Callan Family Office increased its Medline Inc (MDLN) stake by 18% in Q2 2026, buying an estimated $76.5K and bringing the position to 12,297 shares worth $485K. The position accounts for 0.01% of the portfolio, ranked #829.

Callan Family Office first reported a position in MDLN in Q1 2026 and has held it in 2 quarters since. 231 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Callan Family Office held 12,297 shares of Medline Inc worth $485K as of Q2 2026.
  • Callan Family Office bought 1,899 Medline Inc shares in Q2 2026, an estimated $76.5K.
  • Medline Inc made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #829 holding.
  • Callan Family Office first reported a position in Medline Inc in Q1 2026 and has held it in 2 quarters since.
  • 231 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.